LJPC

La Jolla Pharmaceutical Co

NASDAQ

Add Alert

116

LJPC

La Jolla Pharmaceutical Co

NASDAQ

Add Alert

116

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

starbuxsux Free

07/11/22 9:32 AM

Post #3,141

Innoviva to Acquire La Jolla Pharmaceutical Company
https://finance.yahoo.com/news/innoviva-acquire-la-jolla-pharmaceutical-113200698.html

stocksrising Free

03/09/22 9:21 AM

Post #3,140

Re: #3,137: @starbuxsux - La Jolla Pharmaceutical Company Announces Financial Results for

If you read 10-k, they show additional $5m in buyback. So far ( to date) they purchased less than $4m .. should move higher especially if they can increase sales and or M&A

stocksrising Free

11/17/21 9:00 AM

Post #3,139

Re: #3,137: @starbuxsux - La Jolla Pharmaceutical Company Announces Financial Results for

LJPC) today announced that it will commence a share repurchase plan for up to $10 million of the Company’s common stock. Repurchases may be made from time to time at the Company’s discretion. The plan has no time limit and can be discontinued at any time.

stocksrising Free

08/26/21 10:39 PM

Post #3,138

Re: #3,137: @starbuxsux - La Jolla Pharmaceutical Company Announces Financial Results for

It’s happening, higher base

starbuxsux Free

08/05/21 9:48 AM

Post #3,137

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress

https://www.businesswire.com/news/home/20210805005263/en/

stocksrising Free

08/04/21 8:29 AM

Post #3,136

Re: #3,135: @starbuxsux - ???

Maybe we can get some extraordinary top-line growth with both of our commercialized drugs! Wish Mgmt would do CC after eps release!! Talk about new drugs in the pipe.

starbuxsux Free

07/21/21 12:00 PM

Post #3,135

Re: #3,132: @rusty8350 - Tang sending it

???

stocksrising Free

06/01/21 7:00 PM

Post #3,134

Re: #3,133: @starbuxsux - Apparently not enough

KT’s appetite never ends! He gobbling up all the shares and soon will be close to 50%??

starbuxsux Free

05/28/21 2:07 PM

Post #3,133

Re: #3,132: @rusty8350 - Tang sending it

Apparently not enough

rusty8350

05/26/21 7:17 PM

Post #3,132

Re: #3,131: @starbuxsux - WTF

Tang sending it

starbuxsux Free

05/26/21 3:45 PM

Post #3,131

WTF

stocksrising Free

03/17/21 7:52 PM

Post #3,130

Re: #3,129: @rusty8350 - https://www.google.com/amp/s/www.analystratings.com/articles/la-jolla-pharma-ljp

Thanks Bud, GL

rusty8350

03/15/21 11:28 AM

Post #3,129

Re: #3,128: @stocksrising - By whom?

https://www.google.com/amp/s/www.analystratings.com/articles/la-jolla-pharma-ljpc-receives-a-buy-from-chardan-capital/amp/

stocksrising Free

03/15/21 8:17 AM

Post #3,128

Re: #3,127: @rusty8350 - Upgraded today. $15 PT

By whom?

rusty8350

03/10/21 4:15 PM

Post #3,127

Upgraded today. $15 PT

starbuxsux Free

03/08/21 1:37 PM

Post #3,126

Re: #3,125: @rusty8350 - They reported this morning.... beat on revenue. More

Good to know! I looked at Earnings Whisper and it said 15th go figure

Not much movement from it though

rusty8350

03/08/21 1:34 PM

Post #3,125

Re: #3,124: @starbuxsux - March 15th before the open

They reported this morning.... beat on revenue. More cost reductions. Have over $40 million in cash now. Looking good on the balance sheet and growing revenue every quarter

starbuxsux Free

03/08/21 1:08 PM

Post #3,124

Re: #3,123: @stocksrising - Is/Are today the Financials are released Q4,

March 15th before the open

stocksrising Free

03/08/21 8:02 AM

Post #3,123

Re: #3,122: @rusty8350 - Tang has a lot going on with different

Is/Are today the Financials are released Q4, Annual? Any guidance, Conf call please!!

rusty8350

02/10/21 9:15 AM

Post #3,122

Re: #3,121: @stocksrising - Totally agree! Would be great if we could

Tang has a lot going on with different tickets. I assume he has some grand plan to bring it all together. Maybe he’s not ready yet to share. I’m kinda a believer that he has a chance to bring significant value here

stocksrising Free

02/09/21 11:15 AM

Post #3,121

Re: #3,120: @rusty8350 - Maybe he will. Never know. They’re going to

Totally agree! Would be great if we could get some sell side analysts involved! Communication from MgMt ( conferences, ‘fire side’ chats helpful

rusty8350

02/08/21 6:59 PM

Post #3,120

Re: #3,119: @stocksrising - Agreed! Good volumes last couple days, Blackrock filing

Maybe he will. Never know. They’re going to eventually have to start addressing investors more. I’ve been very pleased with my returns here but I believe this can really break out higher

stocksrising Free

02/04/21 3:09 PM

Post #3,119

Re: #3,118: @rusty8350 - Been really nice since announcing that $100+ million

Agreed! Good volumes last couple days, Blackrock filing 13g, etc..Just wish new CEO would do Q&A after EPS release next month

rusty8350

02/04/21 12:24 PM

Post #3,118

Re: #3,117: @stocksrising - Nice movement ??

Been really nice since announcing that $100+ million dollar deal last month. Prob something more going on here now. Expect news soon

stocksrising Free

02/04/21 10:41 AM

Post #3,117

Re: #3,116: @rusty8350 - Nice movement here lately. Push for $10+ coming?

Nice movement ??

rusty8350

02/03/21 8:47 PM

Post #3,116

Nice movement here lately. Push for $10+ coming?

stocksrising Free

01/26/21 6:01 PM

Post #3,115

Re: #3,114: @rusty8350 - Already exists doesn’t it? Everest medicine ..... should

Maybe w/ just Gia, I’m thinking same template like Paion( both
Giapreza and Xerava Together)..we shall see soon, hopefully sales gained some traction here in the states??
Been a slow ramp up w/ Just Gia

rusty8350

01/26/21 5:21 PM

Post #3,114

Re: #3,113: @stocksrising - Or maybe Asian licensing agreement like recent EU

Already exists doesn’t it? Everest medicine ..... should have an update on that anytime.

Also interesting it had such a large volume of shorts on that spike on the news on Jan 12th. Yet it’s held gains and is going back up on relatively low volume. Could squeeze them

stocksrising Free

01/26/21 4:01 PM

Post #3,113

Re: #3,112: @rusty8350 - Tang prob buying more today

Or maybe Asian licensing agreement like recent EU collaboration?
International expansion now that we have a real CEO

rusty8350

01/26/21 3:45 PM

Post #3,112

Tang prob buying more today

stocksrising Free

01/21/21 10:38 AM

Post #3,111

Re: #3,110: @OCMillionaire - 10$ coming. worth 17$

Agreed! Finally starting to build out business internationally!
Tang owns 30+%, low floater

OCMillionaire Free

01/19/21 12:58 PM

Post #3,110

10$ coming. worth 17$

stocksrising Free

01/14/21 6:28 PM

Post #3,109

Re: #3,108: @rusty8350 - Swing and a miss on that assessment?

Shhhh, she’s a blessing on everything she touches lately, lol ?? ?? any where from 35-200% higher once the “Charts’ are posted ??

rusty8350

01/14/21 5:22 PM

Post #3,108

Re: #3,105: @ClayTrader - * * $LJPC Video Chart 01-12-2021 * *

Swing and a miss on that assessment?

stocksrising Free

01/12/21 6:01 PM

Post #3,107

Re: #3,104: @starbuxsux - Yes indeed, I have been loaded since the

Same here Star, almost picked off 2000 more at $4.10 as news hit , missed it ! Lol

stocksrising Free

01/12/21 5:55 PM

Post #3,106

Re: #3,105: @ClayTrader - * * $LJPC Video Chart 01-12-2021 * *

I love this lady CT??

ClayTrader Free

01/12/21 5:00 PM

Post #3,105

* * $LJPC Video Chart 01-12-2021 * *

Link to Video - click here to watch the technical chart video

starbuxsux Free

01/12/21 1:14 PM

Post #3,104

Re: #3,103: @stocksrising - Finally management exists and working for US!!

Yes indeed, I have been loaded since the Covid crash and ready for take off back to $20's

stocksrising Free

01/12/21 7:52 AM

Post #3,103

Re: #3,102: @Baha1844 - It has to be some kind of merger

Finally management exists and working for US!!

Baha1844

09/20/20 4:55 PM

Post #3,102

Re: #3,101: @rusty8350 - Yeah I don’t disagree. Public company’s are supposed

It has to be some kind of merger so the Company closed the headquarter, no employees and Auctioned all the equipments. We may get an updates any day.

rusty8350

09/18/20 5:35 PM

Post #3,101

Re: #3,100: @stocksrising - that's not how you run a publicly traded

Yeah I don’t disagree. Public company’s are supposed to be more transparent than this. But I’m sure there’s something big in the works behind the curtains here and it will be revealed, eventually.

stocksrising Free

09/18/20 10:18 AM

Post #3,100

Re: #3,099: @rusty8350 - I honestly don’t care how transparent they are.

that's not how you run a publicly traded company (especially mkt caps of $100mm+).. that's why we have 0 sell/buy side analysts..we have a great story to tell, but it's falling on deaf ears, imho..nonetheless, somethings up:)

rusty8350

09/16/20 3:58 PM

Post #3,099

Re: #3,098: @stocksrising - agreed! just wish they were more shareholder friendly

I honestly don’t care how transparent they are. I’m sure they’ll share news when they have it. No way Tang is putting that much on the line and buying up the float for nothing. Something is up here for sure.

stocksrising Free

09/15/20 11:22 AM

Post #3,098

Re: #3,097: @rusty8350 - Has to be something good in the works

agreed! just wish they were more shareholder friendly but perhaps with Edwards as new CEO, they will hold qtrly conf calls. the previous CFO and i would speak occasionally, but of course nothing 'insider' based... they did have high hopes on the malaria drug( more for voucher reasons-could have been worth 100mm+) but that went to competing private company.. maybe Kevin and Edwards can buy them, lol.. glta

rusty8350

09/15/20 9:05 AM

Post #3,097

Re: #3,096: @stocksrising - Yes, about 35% and climbing especially in the

Has to be something good in the works here with all this insider buying. The tetraphase buyout looks promising as well. Interesting news with them letting the contract for their facility expire. Could be a buyout or something else like a merger etc. I’m in this heavily, I see too much potential.

stocksrising Free

09/14/20 8:08 PM

Post #3,096

Yes, about 35% and climbing especially in the 3’s..we also have Director Ramsay buying albeit small but that says something! Now if we see Larry Edwards and other directors, then something big down the pike!

rusty8350

09/09/20 8:02 PM

Post #3,095

Kevin Tang owns what now like 35-40% of this company? And he keeps buying

stocksrising Free

08/13/20 10:20 AM

Post #3,094

What are the chances that Ljpc Hq moves to Tetra’s HQ in Massachusetts?

starbuxsux Free

03/05/20 10:41 AM

Post #3,093

No one at La Jolla is working on a Coronavirus vaccine??????????????????

Pitiful!

Let's go bitches! Get with the program!

starbuxsux Free

03/02/20 10:18 AM

Post #3,092

$LJPC La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2019

GlobeNewswire GlobeNewswire•March 2, 2020

For the three months ended December 31, 2019, GIAPREZA U.S. net sales were $7.3 million, up 74% from the three months ended December 31, 2018 and up 28% from the three months ended September 30, 2019. Vials of GIAPREZA shipped from distributors to hospitals (hospital demand) grew 74% for the three months ended December 31, 2019 as compared to the three months ended December 31, 2018 and 18% as compared to the three months ended September 30, 2019. GIAPREZA U.S. net sales were $23.1 million in 2019 compared to $10.1 million in 2018, an increase of 129%. La Jolla announced the commercial availability of GIAPREZA in the U.S. in March 2018.

La Jolla’s net loss for the three and twelve months ended December 31, 2019 was $25.2 million and $116.5 million, or $0.93 per share and $4.30 per share, respectively, compared to $45.4 million and $199.5 million, or $1.73 per share and $7.85 per share, respectively, for the same periods in 2018.

As of December 31, 2019, La Jolla had $87.8 million in cash, compared to $172.6 million as of December 31, 2018. Net cash used in operating activities for the three and twelve months ended December 31, 2019 was $17.1 million and $85.0 million, respectively, compared to $32.0 million and $152.4 million, respectively, for the same periods in 2018. La Jolla has no debt.

https://finance.yahoo.com/news/la-jolla-pharmaceutical-company-announces-133010981.html

Older

La Jolla Pharmaceutical Co (LJPC)

Followers	116	Posters	487
Posts (Today)	0	Posts (Total)	3141
Created	10/21/04	Type	Free
Moderators

http://www.ljpc.com/

http://finance.yahoo.com/q/h?s=LJPC

La Jolla Pharmaceutical Company, a biopharmaceutical company, engages in the research and development of pharmaceutical products in the United States. Its principal product in development is Riquent, which is designed to treat lupus renal disease by preventing or delaying renal flares. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. Riquent is in Phase III clinical trial. The company also develops small molecules for the treatment of autoimmune diseases, and acute and chronic inflammatory disorders. La Jolla Pharmaceutical Company was founded in 1989 and is based in San Diego, California.

Riquent

Riquent (abetimus sodium)

Riquent (abetimus sodium) is a synthetic oligonucleotide conjugate composed of 4 identical strands of dsDNA (20BP in length) that are linked through a triethyleneglycol-based platform. It binds anti-dsDNA Ab and the complex is cleared via the immune system, thus ridding the body of one of the primary pathogenic antibody associated with lupus.

Lupus nephritis is a serious and potentially fatal orphan disease treated primarily by nephrologists and rheumatologists. Currently, there are no products specifically approved to treat lupus renal disease.

La Jolla Pharmaceutical is investigating Riquent for the treatment of lupus renal disease by preventing or delaying renal flares, a leading cause of sickness and death in lupus patients, and improving proteinuria. Proteinuria is an indicator of abnormal renal function. Riquent has been well tolerated in all 14 clinical trials, with no overall difference in the adverse event profiles for Riquent-treated patients compared with placebo-treated patients. Riquent specifically reduces circulating levels of anti-dsDNA antibodies and is also designed to specifically suppress the B cells that make these antibodies. Decreases in these antibodies are believed to be associated with a decreased risk of renal flare. Although clinical benefit has not yet been proven, Riquent treatment has significantly reduced these antibody levels in all clinical trials in which they were measured.